Welcome : Guest

Neuren Pharmaceuticals Ltd. (New Zealand) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Neuren Pharmaceuticals Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 22 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-24209
Price: $1100
Company Type: Public
Pages: 23
Date: November 2016
Market Data Tables: 22

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Central Nervous System (CNS)......2
Table 1: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......2
Table 2: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI's, Tranquilizers, and Others......3
Deep Brain Stimulation (DBS)......4
Table 3: Deep Brain Stimulation (DBS) Market Worldwide (2015) in US$ Million......4
Nerve Stimulation......5
Table 4: Nerve Stimulation Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), and Others......5
Neuro Stimulation......6
Table 5: Neuro Stimulation Market Worldwide (2015) in US$ Million......6
Neurology......7
Table 6: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......7
Neuromodulation......8
Table 7: Neuromodulation Market by Category in the US (2015) - Percentage Share Breakdown by Value for Deep Brain, Sacral Nerve, Spinal Cord, and Vagus Nerve......8
Table 8: Neuromodulation Market by Company Worldwide (2014) - Percentage Breakdown by Value Sales for Boston Scientific Corporation, Cyberonics, Inc., Medtronic, Inc., and St. Jude Medical, Inc.......9
Neurosurgery......10
Table 9: Neurosurgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......10
Neurovascular Devices......11
Table 10: Neurovascular Device Market Worldwide by Value Sales (2015) - Percentage Share Breakdown for Access Devices, Acute Ischemic Stroke Devices, Aneursm Stents, Embolic Coils, Flow Diverters, ICAD Stents & Balloons, Liquid Embolic Systems, Remodelling Balloons and Others......11
Neuroendocrine Tumors (NETs)......12
Table 11: Neuroendocrine Tumors (NETs) by Area in the US (2015) - Percentage Share Breakdown by Value for Gls & Unknown, Lung & Thymus, and Pancreas......12
Table 12: No. of Neuroendocrine Tumours Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......13
Primary Brain Tumors......14
Table 13: Primary Brain Tumors by Type in the US (2015) - Percentage Market Share Breakdown for Anaplastic Astrocytoma, Glioblastoma, Oligodendroma, and Others......14
Alzheimer's Diseases......15
Table 14: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......15
Table 15: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......16
Deep Brain Stimulation (DBS) Systems......17
Table 16: Market Shares of Leading Deep Brain Stimulation (DBS) Systems Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Medtronic plc, and Others......17
Hospital Services for Acquired Brain Injury......18
Table 17: Market Shares of Leading Hospital Service Providers for Acquired Brain Injury in the UK (2015) - Percentage Share Breakdown by Value for Disabilities Trust, Huntercombe Group, Priory Group, Royal Hospital for Neuro-Disability and Others......18
Nerve Growth Factor (NGF)......19
Table 18: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co., Ltd., Staidson (Beijing) Biopharmaceuticals Co., Ltd., Xiamen Bioway Pku Co., Ltd., and Others......19
Neuromodulation Devices......20
Table 19: Market Shares of Leading Neuromodulation Device Manufacturers Worldwide (2014) - Percentage Breakdown by Value for Boston Scientific Corporation, Cyberonics, Inc., Medtronic, Inc. and St. Jude Medical, Inc.......20
Table 20: Market Shares of Leading Neuromodulator Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ipsen and Galderma S.A., Allergan and Others......21
Neurophysiology Research Products......22
Table 21: Market Shares of Leading Neurophysiology Research Products Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ambu A/S, Natus Medical Inc., Rhythmlink International, LLC, and Others......22
Neurosurgery......23
Table 22: Market Shares of Leading Neurosurgery Service Providers in the US (2015) - Percentage Share Breakdown by Value for Integra LifeSciences Corporation, and Others......23